- $855.34bn
- $890.58bn
- $65.18bn
RCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
AnnouncementREG - Stock Exch Notice - Admission to ISM - 04/03/2026
AnnouncementREG - Stock Exch Notice - Admission to ISM - 02/03/2026
AnnouncementREG - Stock Exch Notice - Admission to ISM - 20/02/2026
AnnouncementREG - Stock Exch Notice - Admission to ISM - 05/02/2026
AnnouncementREG - Stock Exch Notice - Admission to ISM - 23/01/2026
AnnouncementRCS - Redx Pharma Limited - US FDA lifts Partial Clinical Hold on Zelasudil
AnnouncementREG - Stock Exch Notice - Admission to Trading - 05/12/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 25/11/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 14/11/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 12/11/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 10/11/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 21/10/2025
AnnouncementREG - Stock Exch Notice - Admission to Trading - 16/09/2025
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to ISM - 15/09/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 26/08/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 15/08/2025
AnnouncementREG - Stock Exch Notice - Admission to ISM - 23/07/2025
Announcement